Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel compounds as histone deacetylase inhibitors

a technology of histone deacetylase and compound, which is applied in the direction of plant growth regulators, biocide, animal husbandry, etc., can solve the problems of tumorigenic transformation, destabilisation of the interaction of histones with dna, etc., and achieve the effect of improving the condition of patients

Inactive Publication Date: 2009-04-02
4SC +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The hydroxamic acid compounds effectively induce differentiation and apoptosis in a wide variety of cancer cells, offering a therapeutic approach that regulates cell proliferation, survival, and gene expression, potentially reducing side effects and improving clinical outcomes.

Problems solved by technology

In the case of histone hyperacetylation, changes in electrostatic attraction for DNA and steric hindrance introduced by the hydrophobic acetyl group leads to destabilisation of the interaction of histones with DNA.
Disruption of these mechanisms gives rise to transcriptional misregulation and may lead to tumorigenic transformation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel compounds as histone deacetylase inhibitors
  • Novel compounds as histone deacetylase inhibitors
  • Novel compounds as histone deacetylase inhibitors

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of Compound 1 (3-Cyclopentyl-N-hydroxy-propionamide)

[0091]To a solution of 3-Cyclopentyl-propionyl chloride (11.0 mL, 11.6 g, 72.0 mmol) in dichloromethane (50 mL) hydroxylamine hydrochloride (5.00 g, 72.0 mmol) and sodium bicarbonate (12.0 g, 144 mmol) were added. After stirring for 24 h at room temp. the reaction was quenched by addition of saturated ammonium chloride solution (50 mL). The layers were separated. The water layer was extracted with ethyl acetate (4×50 mL). The solvent of the combined organic layers was removed in vacuo. Precipitation of the crude product out of ethyl acetate by adding petroleum ether yielded the hydroxamate (5.25 g, 33.4 mmol, 46%) as a white solid. 1H NMR (300 MHz, [D6-DMSO]: δ=0.74-0.91 (m, 2H), 1.05-1.25 (m, 4H), 1.36 (q, J=7.4 Hz, 4H), 1.54-1.71 (m, 5H), 1.94 (t, J=7.6 Hz, 2H), 8.59 (s, 1H) and 10.28 (s, 1H) (NH and OH). 13C NMR (75 MHz, [D6-DMSO]: δ=25.6, 26.0, 29.7, 32.4, 36.5, 169.2 (C(═O)NHOH). MS: m / z calcd for (C8H14NO2) [M+H]+ 1...

example 2

Synthesis of Compound 2 (3-Cyclohexyl-N-hydroxy-propionamide)

[0092]To a solution of 3-Cyclohexyl-propionyl chloride (12.1 mL, 12.6 g, 72.0 mmol) in dichloromethane (50-mL) hydroxylamine hydrochloride (5.00 g, 72.0 mmol) and sodium bicarbonate (12.0 g, 144 mmol) were added. After stirring for 24 h at room temperature the reaction was quenched by addition of saturated ammonium chloride solution (50 mL). The layers were separated. The water layer was extracted with ethyl acetate (4×50 mL). The solvent of the combined organic layers was removed in vacuo. Precipitation of the crude product out of ethyl acetate by adding petroleum ether yielded the hydroxamate (7.21 g, 42 mmol, 58%) as a white solid. 1H-NMR (300 MHz, [D6-DMSO]: δ=0.95-1.12 (m, 2H), 1.38-1.69 (m, 6H), 1.62-1.77 (m, 3H), 1.94 (t, J=7.6 Hz, 2H), 8.58 (s, 1H) and 10.28 (s, 1H) (NH and OH); 13C-NMR (75 MHz, [D6-DMSO]: δ=25.0, 31.8, 32.0, 32.3, 39.5, 169.5 (C(═)NHOH); MS: m / z calc. for (C9H17NO2) [M+H]+ 172; found 172.

example 3

Synthesis of Compound 3 (3-Cyclohexyl-N-hydroxy-acrylamide)

[0093]3-Cyclohexyl-acrylic acid ethyl ester: to a cooled solution of oxalyl chloride (11.1 μL, 105 mmol) in dichloromethane (250 mL) was added at −78° C. a solution of dimethylsulfoxide (14.6 mL, 206 mmol) in dichloromethane (250 mL). After 5 min at the same temperature cyclohexylmethanol (10.8 mL, 87.5 mmol) and after additional 5 min triethylamine (60.7 mL, 438 mmol) were added. The reaction remained at −78° C. for two hours and then let warm to room temperature. The solvent was removed in vacuo. The resulting aldehyde was used for the next step without further purification. The crude cyclohexanecarbaldehyde was dissolved in toluene (200 mL) and ethanol (150 mL). After 15 min of stirring at 70° C. carbethoxy-methylene triphenylphosphorane (33.6 g, 96.5 mmol) was added in one portion. Stirring was continued for additional 24 hours. The solvent was removed in vacuo. The product was obtained by flash chromatography in 78% yie...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The present invention relates to compounds as inhibitors of enzymes having histone deacetylase activity, to the processes for the preparation of those compounds, and to their use for the treatment of diseases which are associated with hypoacetylation of histones and / or other molecules, or in which induction of hyperacetylation has a beneficial effect for example by inhibition of proliferation and / or induction of differentiation and / or induction of apoptosis in transformed cells, such as cancer. Furthermore, the compounds are useful for the treatment of other proliferative diseases, for therapy or prophylaxis of conditions associated with abnormal gene expression.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is a divisional of U.S. application Ser. No. 10 / 624,571, filed Jul. 23, 2003, which claims priority from Provisional Application Ser. No. 60 / 397,663, filed Jul. 23, 2002, the content of which is incorporated herein by reference in its entirety.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention relates to compounds as inhibitors of enzymes having histone deacetylase activity, to the processes for the preparation of those compounds, and to their use for the treatment of diseases which are associated with hypoacetylation of histones and / or other molecules, or in which induction of hyperacetylation has a beneficial effect for example by inhibition of proliferation and / or induction of differentiation and / or induction of apoptosis in transformed cells, such as cancer. Furthermore, the compounds are useful for the treatment of other proliferative diseases, for therapy or prophylaxis of conditio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/164C07C237/22A61P35/00A61K31/19A61K31/66C07C259/04
CPCC07C259/04C07C2101/14C07C2101/08C07C2601/08C07C2601/14A61P35/00
Inventor MAURER, ALEXANDER B.HOEVELMANN, SASCHAMARTIN, ELKEHENTSCH, BERNDGASSEN, MICHAELKRAUS, JUERGENKRAUSS, ROLFVINCEK, ADAM-SPENCER
Owner 4SC